MEDIUM confidence: 100% data completeness, but the composite (45) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-08-30.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $7 avg across 11 analysts.
Buy-rated share 23% → 26% over ~3 months (+2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $-0.12 | $-0.10 | +17.9% |
| May 2026 | $-0.07 | $-0.05 | +25.2% |
| Feb 2026 | $-0.03 | $0.03 | +197.0% |
| Nov 2025 | $-0.12 | $-0.06 | +50.8% |
| Aug 2025 | $-0.16 | $-0.13 | +18.8% |
| Apr 2025 | $-0.13 | $-0.08 | +39.9% |
| Feb 2025 | $-0.04 | $0.01 | +125.7% |
| Oct 2024 | $-0.14 | $0.08 | +159.2% |
Net insider -$50.7M over 180 days (0 open-market buys, 24 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4.1B— | $4.6B+11.8% | $4.6B+0.1% | $5.4B+16.4% | $5.9B+10.6% |
| EPS (dil.) | $-0.31— | $-0.89n/m | $-0.82n/m | $-0.42n/m | $-0.27n/m |
| Free Cash Flow | $223M— | $55M-75.2% | $35M-37.1% | $219M+528.4% | $437M+99.9% |
| Gross Margin | 57.5% | 60.6%+3.1pp | 54.1%-6.4pp | 53.9%-0.3pp | 55.0%+1.1pp |
| Operating Margin | -17.1% | -30.3%-13.3pp | -30.4%-0.0pp | -14.7%+15.7pp | -9.0%+5.7pp |
| Net Margin | -11.9% | -31.1%-19.2pp | -28.7%+2.4pp | -13.0%+15.7pp | -7.8%+5.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 7.3%/yr (revenue basis).
Base free cash flow $230M (avg FY2023–FY2025; latest year $437M) · equity value $8.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 45 for SNAP indicates a neutral outlook, driven by a mix of positive and negative factors. The stock scores high on growth and momentum, with notable revenue and EPS growth rates of 10.6% and 35.7%, respectively, as well as a bullish 50-day versus 200-day moving average trend. However, it trades at a premium, with a high EV/EBITDA of 882.2, and exhibits weak profitability, with an ROE of -14.6% and an operating margin of -5.1%, weighing down its overall score. The short-term score is slightly higher than the long-term score, at 49 versus 42.